Ex10.187 Jul Sup Ind 5.75-2022


EX 10.187
EXECUTION VERSION




SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of July 10, 2014, among Endo Netherlands B.V. (the “Guaranteeing Subsidiary”), a subsidiary of Endo Limited, a Delaware corporation (the “Company”), the Issuer, the Co-Obligor, the other Guarantors (each, as defined in the Indenture referred to below) and Wells Fargo Bank, National Association, as trustee under the Indenture referred to below (the “Trustee”).
W I T N E S S E T H
WHEREAS, Endo Finance Co., a Delaware corporation, has heretofore executed and delivered to the Trustee an indenture, dated as of December 19, 2013, as supplemented, amended and restated by a supplemental indenture, dated as of February 28, 2014, and as further supplemented by a supplemental indenture, dated as of May 28, 2014, in each case, among Endo Finance LLC, a Delaware limited liability company and successor to Endo Finance Co., Endo Finco Inc., a Delaware corporation, the Guarantors party thereto and the Trustee (as so supplemented, amended and restated, the “Indenture”), providing for the issuance of 5.75% Senior Notes due 2022 (the “Notes”); 
WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Issuer’s and the Co-Obligor’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein (the “Note Guarantee”); 
WHEREAS, this Supplemental Indenture has not resulted in a material modification of the Notes for Foreign Account Tax Compliance Act purposes; and
WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiary and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:
1.    CAPITALIZED TERMS.  Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2.    AGREEMENT TO GUARANTEE.  The Guaranteeing Subsidiary hereby agrees to provide an unconditional Guarantee on the terms and subject to the conditions set forth in the Note Guarantee and in the Indenture including but not limited to Article 10 thereof.
4.    NO RECOURSE AGAINST OTHERS.  No director, officer, employee, incorporator or stockholder of the Issuer, the Co-Obligor or any Guarantor, as such, will have any liability for any obligations of the Issuer, Co-Obligor or the Guarantors under the Notes, the Indenture, this Supplemental Indenture, the Note Guarantees or for any claim based on, in respect of, or by reason of, such obligations or their creation.  Each Holder of Notes by accepting a Note waives and releases all such liability.  The waiver and release are part of the consideration for issuance of the Notes.  The waiver may not be effective to waive liabilities under the federal securities laws.







5.    NEW YORK LAW TO GOVERN; WAIVER OF JURY TRIAL.  THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.  EACH OF THE ISSUER, THE CO-OBLIGOR AND THE GUARANTORS CONSENTS AND IRREVOCABLY SUBMITS TO THE JURISDICTION OF ANY NEW YORK STATE OR U.S. FEDERAL COURT LOCATED IN THE BOROUGH OF MANHATTAN, CITY OF NEW YORK, COUNTY OF NEW YORK, STATE OF NEW YORK IN RELATION TO ANY LEGAL ACTION OR PROCEEDING (I) ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS INDENTURE, AS SUPPLEMENTED, THE NOTES, THE GUARANTEES AND ANY RELATED DOCUMENTS AND/OR (II) ARISING UNDER ANY U.S. FEDERAL OR U.S. STATE SECURITIES LAWS IN RESPECT OF THE NOTES, THE GUARANTEES AND ANY SECURITIES ISSUED PURSUANT TO THE TERMS OF THE INDENTURE, AS SUPPLEMENTED.  EACH OF THE ISSUER, THE CO-OBLIGOR AND THE GUARANTORS WAIVES ANY OBJECTION TO PROCEEDINGS IN ANY SUCH COURTS, WHETHER ON THE GROUND OF VENUE OR ON THE GROUND THAT THE PROCEEDINGS HAVE BEEN BROUGHT IN AN INCONVENIENT FORUM.  EACH OF THE ISSUER, THE CO-OBLIGOR AND THE GUARANTORS, TO THE EXTENT ORGANIZED OUTSIDE OF THE UNITED STATES, SHALL APPOINT CT CORPORATION SYSTEM, 111 EIGHTH AVENUE, 13TH FLOOR, NEW YORK, NY 10011, AS ITS AGENT FOR SERVICE OF PROCESS IN ANY SUCH SUIT, ACTION OR PROCEEDING AND AGREES THAT SERVICE OF PROCESS UPON SAID AUTHORIZED AGENT SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE OF PROCESS UPON IT IN ANY SUCH SUIT, ACTION OR PROCEEDING. EACH OF THE ISSUER, THE CO-OBLIGOR AND THE GUARANTORS AGREES TO DELIVER, UPON THE EXECUTION AND DELIVERY OF THIS SUPPLEMENTAL INDENTURE, A WRITTEN ACCEPTANCE BY SUCH AGENT OF ITS APPOINTMENT AS SUCH AGENT. EACH OF THE ISSUER, THE CO-OBLIGOR AND THE GUARANTORS, TO THE EXTENT ORGANIZED OUTSIDE OF THE UNITED STATES, FURTHER AGREES TO TAKE ANY AND ALL ACTION, INCLUDING THE FILING OF ANY AND ALL SUCH DOCUMENTS AND INSTRUMENTS, AS MAY BE REASONABLY NECESSARY TO CONTINUE SUCH DESIGNATION AND APPOINTMENT OF CT CORPORATION SYSTEM IN FULL FORCE AND EFFECT FOR SO LONG AS THE INDENTURE, AS SUPPLEMENTED, REMAINS IN FORCE.  THE ISSUER, THE CO-OBLIGOR, THE TRUSTEE AND EACH OF THE GUARANTORS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.
6.    COUNTERPARTS.  The parties may sign any number of copies of this Supplemental Indenture.  Each signed copy (which may be provided via facsimile or other electronic transmission) shall be an original, but all of them together represent the same agreement.  
7.    EFFECT OF HEADINGS.  The Section headings herein are for convenience only and shall not affect the construction hereof.
8.    THE TRUSTEE.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary and the Issuer.







IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.
 
	
			
	ENDO NETHERLANDS B.V., as Guaranteeing Subsidiary

	 
	 
	 

	By:
	/s/Blaine Davis                                                       

	 
	Name:
	Blaine Davis

	 
	Title:
	Managing Director A

	 
	 
	 

	By:
	/s/Gert Jan Rietberg                                                 

	 
	Name:
	Gert Jan Rietberg

	 
	Title:
	Managing Director B








 


[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]








	
		
	ENDO FINANCE LLC 
  as an Issuer

	by ENDO LUXEMBOURG FINANCE  COMPANY I 

	S.À R.L., its sole member

	 
	 

	By:
	/s/ Andrew O'Shea                                                    

	Name:
	Andrew O'Shea

	Title:
	B Manager









[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
			
	ENDO FINCO INC.
  as Co-Obligor

	 
	 
	 

	By:
	/s/ Deanna Voss                                                        

	Name:
	Deanna Voss

	Title:
	Secretary











[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
			
	ENDO LLC 
 ENDO U.S. INC.
  each, as a Guarantor

	 
	 
	 

	By:
	/s/ Deanna Voss                                                        

	Name:
	Deanna Voss

	Title:
	Secretary






 

[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
		
	ENDO HEALTH SOLUTIONS INC. 
ENDO PHARMACEUTICALS INC. 
ENDO PHARMACEUTICALS SOLUTIONS INC. 
ENDO PHARMACEUTICALS VALERA INC. 
GENERICS INTERNATIONAL (US PARENT), INC. 
GENERICS INTERNATIONAL (US MIDCO), INC.  
GENERICS INTERNATIONAL (US HOLDCO), INC. 
GENERICS INTERNATIONAL (US), INC. 
AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.  
AMERICAN MEDICAL SYSTEMS, INC. 
AMS RESEARCH CORPORATION    
AMS SALES CORPORATION 
LASERSCOPE 
  each, as a Guarantor

	 
	 

	By:
	/s/ Deanna Voss                                                         

	Name:
	Deanna Voss

	Title:
	Assistant Secretary






 

[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
		
	GENERICS BIDCO I, LLC 
VINTAGE PHARMACEUTICALS, LLC 
GENERICS BIDCO II, LLC 
MOORES MILL PROPERTIES LLC 
WOOD PARK PROPERTIES LLC 
QUARTZ SPECIALTY PHARMACEUTICALS, LLC 
  each, as a Guarantor 
  by GENERICS INTERNATIONAL (US), INC., 
  its manager

	 
	 

	By:
	/s/ Deanna Voss                                                         

	Name:
	Deanna Voss

	Title:
	Assistant Secretary











[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
			
	LEDGEMONT ROYALTY SUB LLC 
  as a Guarantor 
  by ENDO PHARMACEUTICALS SOLUTIONS   INC., 
  its manager

	 
	 
	 

	By:
	/s/ Deanna Voss                                                        

	Name:
	Deanna Voss

	Title:
	Assistant Secretary







[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
	
	ENDO LIMITED 
  as a Guarantor

	 

	By:  /s/ Blaine Davis                                                              

	Name: Blaine Davis

	Title: Authorized Signatory

	 

	ENDO VENTURES LIMITED 
  as a Guarantor

	 

	By:  /s/ Blaine Davis                                                              

	Name: Blaine Davis

	Title: Authorized Signatory

	 

	ENDO MANAGEMENT LIMITED 
  as a Guarantor

	 

	By:  /s/ Blaine Davis                                                              

	Name: Blaine Davis

	Title: Authorized Signatory

	 

	ENDO FINANCE LIMITED 
  as a Guarantor

	 

	By:  /s/ Blaine Davis                                                              

	Name: Blaine Davis

	Title: Authorized Signatory







[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
	
	ENDO LUXEMBOURG HOLDING COMPANY S.À R.L. 
  as a Guarantor

	 

	By: /s/ Andrew O'Shea                                                      

	Name: Andrew O'Shea

	Title:   B Manager

	 

	ENDO LUXEMBOURG HOLDING COMPANY I S.À R.L. 
  as a Guarantor

	 

	By: /s/ Andrew O'Shea                                                      

	Name: Andrew O'Shea

	Title:   B Manager

	 

	ENDO LUXEMBOURG HOLDING COMPANY II S.À R.L. 
  as a Guarantor

	 

	By: /s/ Andrew O'Shea                                                      

	Name: Andrew O'Shea

	Title:   B Manager









[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
	
	PALADIN LABS CANADIAN HOLDING INC. 
  as a Guarantor

	 

	By: /s/ Mark Beaudet                                                             

	Name: Mark Beaudet

	Title:   President

	 

	PALADIN LABS INC. 
  as a Guarantor

	 

	By: /s/ Mark Beaudet                                                             

	Name: Mark Beaudet

	Title:   President









[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
			
	ENDO VENTURES BERMUDA LIMITED, as a Guarantor

	 
	 
	 

	By:
	/s/ Robert Rush                                                        

	 
	Name:
	Robert Rush

	 
	Title:
	Director









[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]










	
			
	WELLS FARGO BANK, NATIONAL ASSOCIATION, 
  as Trustee

	 
	 
	 

	By:
	/s/ Martin G. Reed                                                   

	 
	Name:
	Martin G. Reed

	 
	Title:
	Vice President 













[Signature Page to 5.75% Notes due 2022 Supplemental Indenture]